APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sacubitril Valsartan Sodium Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sacubitril Valsartan Sodium Drugs Market Outlook and Growth Opportunities 2026

27 December 2025202 pages

Choose your research edition.

Industry ResearchSacubitril Valsartan Sodium Drugs Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Sacubitril Valsartan Sodium Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Sacubitril Valsartan Sodium Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sacubitril Valsartan Sodium Drugs Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Sacubitril Valsartan Sodium Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Sacubitril Valsartan Sodium Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sacubitril Valsartan Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sacubitril Valsartan Sodium Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sacubitril Valsartan Sodium Drugs market include Addii Biotech, Arlak Corazon, Cipla, Farmanova pharma, General Pharmaceuticals, MSN, Novartis, Sanof and Changzhou Pharmaceutical Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sacubitril Valsartan Sodium Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sacubitril Valsartan Sodium Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sacubitril Valsartan Sodium Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sacubitril Valsartan Sodium Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Sacubitril Valsartan Sodium Drugs Segment by Company

Addii Biotech

Arlak Corazon

Cipla

Farmanova pharma

General Pharmaceuticals

MSN

Novartis

Sanof

Changzhou Pharmaceutical Factory

Chengdu Brilliant Pharmaceutical

TC Pharmaceuticals (Jiangsu)

Sino Therapeutics

Kelun Pharmaceutical

Qilu Pharmaceutical

Shenzhen Salubris Pharmaceuticals

CSPC Ouyi Pharmaceutical

Sihuan Pharmaceutical

Zhejiang AngLiKang Pharmaceutical

Zhejiang Nord Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Sacubitril Valsartan Sodium Drugs Segment by Type

Tablets

Oral Pellets

Sacubitril Valsartan Sodium Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Sacubitril Valsartan Sodium Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sacubitril Valsartan Sodium Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sacubitril Valsartan Sodium Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sacubitril Valsartan Sodium Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Sacubitril Valsartan Sodium Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacubitril Valsartan Sodium Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sacubitril Valsartan Sodium Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacubitril Valsartan Sodium Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sacubitril Valsartan Sodium Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sacubitril Valsartan Sodium Drugs industry.

Chapter 3: Detailed analysis of Sacubitril Valsartan Sodium Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sacubitril Valsartan Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sacubitril Valsartan Sodium Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sacubitril Valsartan Sodium Drugs Industry Trends Table 2. Sacubitril Valsartan Sodium Drugs Industry Drivers Table 3. Sacubitril Valsartan Sodium Drugs Industry Opportunities and Challenges Table 4. Sacubitril Valsartan Sodium Drugs Industry Restraints Table 5. Global Sacubitril Valsartan Sodium Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sacubitril Valsartan Sodium Drugs Revenue Share by Company (2021-2026) Table 7. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Sacubitril Valsartan Sodium Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sacubitril Valsartan Sodium Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sacubitril Valsartan Sodium Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Sacubitril Valsartan Sodium Drugs Company, Product Type & Application Table 13. Global Sacubitril Valsartan Sodium Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sacubitril Valsartan Sodium Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Oral Pellets Table 19. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Sacubitril Valsartan Sodium Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sacubitril Valsartan Sodium Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sacubitril Valsartan Sodium Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Type (2021-2026) Table 28. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Other Table 32. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Sacubitril Valsartan Sodium Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sacubitril Valsartan Sodium Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sacubitril Valsartan Sodium Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Application (2021-2026) Table 41. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Application (2027-2032) Table 42. Global Sacubitril Valsartan Sodium Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Region (2021-2026) Table 45. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Region (2027-2032) Table 47. Global Sacubitril Valsartan Sodium Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sacubitril Valsartan Sodium Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Region (2021-2026) Table 50. Global Sacubitril Valsartan Sodium Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Region (2027-2032) Table 52. Global Sacubitril Valsartan Sodium Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Sacubitril Valsartan Sodium Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Sacubitril Valsartan Sodium Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Sacubitril Valsartan Sodium Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2021-2026) Table 58. Global Sacubitril Valsartan Sodium Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Country (2027-2032) Table 60. Global Sacubitril Valsartan Sodium Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sacubitril Valsartan Sodium Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Sacubitril Valsartan Sodium Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sacubitril Valsartan Sodium Drugs Sales Value Market Share by Country (2027-2032) Table 64. Addii Biotech Company Information Table 65. Addii Biotech Business Overview Table 66. Addii Biotech Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Addii Biotech Sacubitril Valsartan Sodium Drugs Product Portfolio Table 68. Addii Biotech Recent Development Table 69. Arlak Corazon Company Information Table 70. Arlak Corazon Business Overview Table 71. Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Portfolio Table 73. Arlak Corazon Recent Development Table 74. Cipla Company Information Table 75. Cipla Business Overview Table 76. Cipla Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Cipla Sacubitril Valsartan Sodium Drugs Product Portfolio Table 78. Cipla Recent Development Table 79. Farmanova pharma Company Information Table 80. Farmanova pharma Business Overview Table 81. Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Portfolio Table 83. Farmanova pharma Recent Development Table 84. General Pharmaceuticals Company Information Table 85. General Pharmaceuticals Business Overview Table 86. General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio Table 88. General Pharmaceuticals Recent Development Table 89. MSN Company Information Table 90. MSN Business Overview Table 91. MSN Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. MSN Sacubitril Valsartan Sodium Drugs Product Portfolio Table 93. MSN Recent Development Table 94. Novartis Company Information Table 95. Novartis Business Overview Table 96. Novartis Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Novartis Sacubitril Valsartan Sodium Drugs Product Portfolio Table 98. Novartis Recent Development Table 99. Sanof Company Information Table 100. Sanof Business Overview Table 101. Sanof Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sanof Sacubitril Valsartan Sodium Drugs Product Portfolio Table 103. Sanof Recent Development Table 104. Changzhou Pharmaceutical Factory Company Information Table 105. Changzhou Pharmaceutical Factory Business Overview Table 106. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Portfolio Table 108. Changzhou Pharmaceutical Factory Recent Development Table 109. Chengdu Brilliant Pharmaceutical Company Information Table 110. Chengdu Brilliant Pharmaceutical Business Overview Table 111. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 113. Chengdu Brilliant Pharmaceutical Recent Development Table 114. TC Pharmaceuticals (Jiangsu) Company Information Table 115. TC Pharmaceuticals (Jiangsu) Business Overview Table 116. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Portfolio Table 118. TC Pharmaceuticals (Jiangsu) Recent Development Table 119. Sino Therapeutics Company Information Table 120. Sino Therapeutics Business Overview Table 121. Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Portfolio Table 123. Sino Therapeutics Recent Development Table 124. Kelun Pharmaceutical Company Information Table 125. Kelun Pharmaceutical Business Overview Table 126. Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 128. Kelun Pharmaceutical Recent Development Table 129. Qilu Pharmaceutical Company Information Table 130. Qilu Pharmaceutical Business Overview Table 131. Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 133. Qilu Pharmaceutical Recent Development Table 134. Shenzhen Salubris Pharmaceuticals Company Information Table 135. Shenzhen Salubris Pharmaceuticals Business Overview Table 136. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio Table 138. Shenzhen Salubris Pharmaceuticals Recent Development Table 139. CSPC Ouyi Pharmaceutical Company Information Table 140. CSPC Ouyi Pharmaceutical Business Overview Table 141. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 143. CSPC Ouyi Pharmaceutical Recent Development Table 144. Sihuan Pharmaceutical Company Information Table 145. Sihuan Pharmaceutical Business Overview Table 146. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 148. Sihuan Pharmaceutical Recent Development Table 149. Zhejiang AngLiKang Pharmaceutical Company Information Table 150. Zhejiang AngLiKang Pharmaceutical Business Overview Table 151. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 153. Zhejiang AngLiKang Pharmaceutical Recent Development Table 154. Zhejiang Nord Pharmaceutical Company Information Table 155. Zhejiang Nord Pharmaceutical Business Overview Table 156. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 158. Zhejiang Nord Pharmaceutical Recent Development Table 159. Chia Tai Tianqing Pharmaceutical Company Information Table 160. Chia Tai Tianqing Pharmaceutical Business Overview Table 161. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio Table 163. Chia Tai Tianqing Pharmaceutical Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Sacubitril Valsartan Sodium Drugs Distributors List Table 167. Sacubitril Valsartan Sodium Drugs Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Sacubitril Valsartan Sodium Drugs Product Image Figure 2. Global Sacubitril Valsartan Sodium Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sacubitril Valsartan Sodium Drugs Sales (2021-2032) & (K Units) Figure 5. Global Sacubitril Valsartan Sodium Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sacubitril Valsartan Sodium Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Oral Pellets Image Figure 11. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Sacubitril Valsartan Sodium Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sacubitril Valsartan Sodium Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Sacubitril Valsartan Sodium Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Sacubitril Valsartan Sodium Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sacubitril Valsartan Sodium Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Sacubitril Valsartan Sodium Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sacubitril Valsartan Sodium Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sacubitril Valsartan Sodium Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sacubitril Valsartan Sodium Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sacubitril Valsartan Sodium Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sacubitril Valsartan Sodium Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sacubitril Valsartan Sodium Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sacubitril Valsartan Sodium Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Pellets
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Addii Biotech
  • Arlak Corazon
  • Cipla
  • Farmanova pharma
  • General Pharmaceuticals
  • MSN
  • Novartis
  • Sanof
  • Changzhou Pharmaceutical Factory
  • Chengdu Brilliant Pharmaceutical
  • TC Pharmaceuticals (Jiangsu)
  • Sino Therapeutics
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • Shenzhen Salubris Pharmaceuticals
  • CSPC Ouyi Pharmaceutical
  • Sihuan Pharmaceutical
  • Zhejiang AngLiKang Pharmaceutical
  • Zhejiang Nord Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Sacubitril Valsartan Sodium Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Sacubitril Valsartan Sodium Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sacubitril Valsartan Sodium Drugs Market Dynamics
  1. 2.1 Sacubitril Valsartan Sodium Drugs Industry Trends
  2. 2.2 Sacubitril Valsartan Sodium Drugs Industry Drivers
  3. 2.3 Sacubitril Valsartan Sodium Drugs Industry Opportunities and Challenges
  4. 2.4 Sacubitril Valsartan Sodium Drugs Industry Restraints
3 Sacubitril Valsartan Sodium Drugs Market by Company
  1. 3.1 Global Sacubitril Valsartan Sodium Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Sacubitril Valsartan Sodium Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Sacubitril Valsartan Sodium Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Sacubitril Valsartan Sodium Drugs Company Ranking (2024-2026)
  6. 3.6 Global Sacubitril Valsartan Sodium Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Sacubitril Valsartan Sodium Drugs Company Product Type and Application
  8. 3.8 Global Sacubitril Valsartan Sodium Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sacubitril Valsartan Sodium Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sacubitril Valsartan Sodium Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sacubitril Valsartan Sodium Drugs Market by Type
  1. 4.1 Sacubitril Valsartan Sodium Drugs Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Oral Pellets
  4. 4.2 Global Sacubitril Valsartan Sodium Drugs Sales Volume by Type
  5. 4.2.1 Global Sacubitril Valsartan Sodium Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sacubitril Valsartan Sodium Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sacubitril Valsartan Sodium Drugs Sales Value by Type
  9. 4.3.1 Global Sacubitril Valsartan Sodium Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sacubitril Valsartan Sodium Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Type (2021-2032)
5 Sacubitril Valsartan Sodium Drugs Market by Application
  1. 5.1 Sacubitril Valsartan Sodium Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Sacubitril Valsartan Sodium Drugs Sales Volume by Application
  6. 5.2.1 Global Sacubitril Valsartan Sodium Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sacubitril Valsartan Sodium Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sacubitril Valsartan Sodium Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sacubitril Valsartan Sodium Drugs Sales Value by Application
  10. 5.3.1 Global Sacubitril Valsartan Sodium Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sacubitril Valsartan Sodium Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sacubitril Valsartan Sodium Drugs Sales Value Share by Application (2021-2032)
6 Sacubitril Valsartan Sodium Drugs Regional Sales and Value Analysis
  1. 6.1 Global Sacubitril Valsartan Sodium Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sacubitril Valsartan Sodium Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Sacubitril Valsartan Sodium Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Sacubitril Valsartan Sodium Drugs Sales by Region (2027-2032)
  5. 6.3 Global Sacubitril Valsartan Sodium Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sacubitril Valsartan Sodium Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sacubitril Valsartan Sodium Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sacubitril Valsartan Sodium Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Sacubitril Valsartan Sodium Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Sacubitril Valsartan Sodium Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Sacubitril Valsartan Sodium Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Sacubitril Valsartan Sodium Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sacubitril Valsartan Sodium Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sacubitril Valsartan Sodium Drugs Sales Value Share by Country, 2025 VS 2032
7 Sacubitril Valsartan Sodium Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Sacubitril Valsartan Sodium Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sacubitril Valsartan Sodium Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Sacubitril Valsartan Sodium Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Sacubitril Valsartan Sodium Drugs Sales by Country (2027-2032)
  6. 7.4 Global Sacubitril Valsartan Sodium Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sacubitril Valsartan Sodium Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sacubitril Valsartan Sodium Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sacubitril Valsartan Sodium Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sacubitril Valsartan Sodium Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sacubitril Valsartan Sodium Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Addii Biotech
  2. 8.1.1 Addii Biotech Company Information
  3. 8.1.2 Addii Biotech Business Overview
  4. 8.1.3 Addii Biotech Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Addii Biotech Sacubitril Valsartan Sodium Drugs Product Portfolio
  6. 8.1.5 Addii Biotech Recent Developments
  7. 8.2 Arlak Corazon
  8. 8.2.1 Arlak Corazon Company Information
  9. 8.2.2 Arlak Corazon Business Overview
  10. 8.2.3 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Portfolio
  12. 8.2.5 Arlak Corazon Recent Developments
  13. 8.3 Cipla
  14. 8.3.1 Cipla Company Information
  15. 8.3.2 Cipla Business Overview
  16. 8.3.3 Cipla Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cipla Sacubitril Valsartan Sodium Drugs Product Portfolio
  18. 8.3.5 Cipla Recent Developments
  19. 8.4 Farmanova pharma
  20. 8.4.1 Farmanova pharma Company Information
  21. 8.4.2 Farmanova pharma Business Overview
  22. 8.4.3 Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Portfolio
  24. 8.4.5 Farmanova pharma Recent Developments
  25. 8.5 General Pharmaceuticals
  26. 8.5.1 General Pharmaceuticals Company Information
  27. 8.5.2 General Pharmaceuticals Business Overview
  28. 8.5.3 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
  30. 8.5.5 General Pharmaceuticals Recent Developments
  31. 8.6 MSN
  32. 8.6.1 MSN Company Information
  33. 8.6.2 MSN Business Overview
  34. 8.6.3 MSN Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 MSN Sacubitril Valsartan Sodium Drugs Product Portfolio
  36. 8.6.5 MSN Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Sacubitril Valsartan Sodium Drugs Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Sanof
  44. 8.8.1 Sanof Company Information
  45. 8.8.2 Sanof Business Overview
  46. 8.8.3 Sanof Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sanof Sacubitril Valsartan Sodium Drugs Product Portfolio
  48. 8.8.5 Sanof Recent Developments
  49. 8.9 Changzhou Pharmaceutical Factory
  50. 8.9.1 Changzhou Pharmaceutical Factory Company Information
  51. 8.9.2 Changzhou Pharmaceutical Factory Business Overview
  52. 8.9.3 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Portfolio
  54. 8.9.5 Changzhou Pharmaceutical Factory Recent Developments
  55. 8.10 Chengdu Brilliant Pharmaceutical
  56. 8.10.1 Chengdu Brilliant Pharmaceutical Company Information
  57. 8.10.2 Chengdu Brilliant Pharmaceutical Business Overview
  58. 8.10.3 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  60. 8.10.5 Chengdu Brilliant Pharmaceutical Recent Developments
  61. 8.11 TC Pharmaceuticals (Jiangsu)
  62. 8.11.1 TC Pharmaceuticals (Jiangsu) Company Information
  63. 8.11.2 TC Pharmaceuticals (Jiangsu) Business Overview
  64. 8.11.3 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Portfolio
  66. 8.11.5 TC Pharmaceuticals (Jiangsu) Recent Developments
  67. 8.12 Sino Therapeutics
  68. 8.12.1 Sino Therapeutics Company Information
  69. 8.12.2 Sino Therapeutics Business Overview
  70. 8.12.3 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Portfolio
  72. 8.12.5 Sino Therapeutics Recent Developments
  73. 8.13 Kelun Pharmaceutical
  74. 8.13.1 Kelun Pharmaceutical Company Information
  75. 8.13.2 Kelun Pharmaceutical Business Overview
  76. 8.13.3 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  78. 8.13.5 Kelun Pharmaceutical Recent Developments
  79. 8.14 Qilu Pharmaceutical
  80. 8.14.1 Qilu Pharmaceutical Company Information
  81. 8.14.2 Qilu Pharmaceutical Business Overview
  82. 8.14.3 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  84. 8.14.5 Qilu Pharmaceutical Recent Developments
  85. 8.15 Shenzhen Salubris Pharmaceuticals
  86. 8.15.1 Shenzhen Salubris Pharmaceuticals Company Information
  87. 8.15.2 Shenzhen Salubris Pharmaceuticals Business Overview
  88. 8.15.3 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Portfolio
  90. 8.15.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  91. 8.16 CSPC Ouyi Pharmaceutical
  92. 8.16.1 CSPC Ouyi Pharmaceutical Company Information
  93. 8.16.2 CSPC Ouyi Pharmaceutical Business Overview
  94. 8.16.3 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  96. 8.16.5 CSPC Ouyi Pharmaceutical Recent Developments
  97. 8.17 Sihuan Pharmaceutical
  98. 8.17.1 Sihuan Pharmaceutical Company Information
  99. 8.17.2 Sihuan Pharmaceutical Business Overview
  100. 8.17.3 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  102. 8.17.5 Sihuan Pharmaceutical Recent Developments
  103. 8.18 Zhejiang AngLiKang Pharmaceutical
  104. 8.18.1 Zhejiang AngLiKang Pharmaceutical Company Information
  105. 8.18.2 Zhejiang AngLiKang Pharmaceutical Business Overview
  106. 8.18.3 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  108. 8.18.5 Zhejiang AngLiKang Pharmaceutical Recent Developments
  109. 8.19 Zhejiang Nord Pharmaceutical
  110. 8.19.1 Zhejiang Nord Pharmaceutical Company Information
  111. 8.19.2 Zhejiang Nord Pharmaceutical Business Overview
  112. 8.19.3 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  114. 8.19.5 Zhejiang Nord Pharmaceutical Recent Developments
  115. 8.20 Chia Tai Tianqing Pharmaceutical
  116. 8.20.1 Chia Tai Tianqing Pharmaceutical Company Information
  117. 8.20.2 Chia Tai Tianqing Pharmaceutical Business Overview
  118. 8.20.3 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Portfolio
  120. 8.20.5 Chia Tai Tianqing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sacubitril Valsartan Sodium Drugs Value Chain Analysis
  2. 9.1.1 Sacubitril Valsartan Sodium Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sacubitril Valsartan Sodium Drugs Sales Mode & Process
  6. 9.2 Sacubitril Valsartan Sodium Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sacubitril Valsartan Sodium Drugs Distributors
  9. 9.2.3 Sacubitril Valsartan Sodium Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst